Browsing Category
Cost Transformation for Medicines (Biosimilars)
1 post
AbbVie’s Humira gets a U.S. rival, but costs could stay high — benefiting PBMs, but not patients [more competition is coming]
health and tech institute for continuous health transformation Joaquim Cardoso MScChief Researcher & EditorFebruary 4, 2023 EXECUTIVE SUMMARY Amgen…
